PubMed HealthSearch

PubMed · 8690321

Forensic immunochemistry.

Abstract

Immunoassay has been established with polyclonal or monoclonal antibody even for a low molecular weight compound which has no antigenicity. In spite of the cross-reactivities of an antibody and also the difficulty in identification of the compound, an immunoassay is a useful method of choice for the detection of the compound in biological fluids because of the pretreatment simplicity and ability to treat many samples in a short time. Therefore, immunoassay has been established as a sensitive analytical and screening method for use in forensic sciences. In our laboratory, a radioimmunoassay (RIA) and an enzyme immunoassay (EIA) for phenobarbital, and enzyme-linked immunosorbent assays (ELISA) and latex agglutination inhibition reaction tests (LAIRT) for methamphetamine, benzoylecgonine and morphine have been established. These assays are described in addition to the two commercially available immunoassay kits, enzyme multiplied immunoassay technique (EMIT; Syva Co., USA) and Triage Biosite Piagnostics, Inc, USA.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

K Aoki, T Yoshida, Y Kuroiwa. 1996-06-28. Forensic immunochemistry.. https://doi.org/10.1016/0379-0738(96)01936-6

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[Abrupt end of systematic evaluation of the non-prescription drug market relating to psychiatry, neurology and anesthesia].

Between 1984 and 1994 the legally required task force "Advisory Committee to the German Federal Health Office in Matters of Approval and Review of Existing Medicines B3-Psychiatry, Neurology, Anesthesiology" analyzed and evaluated the CNS-active compounds that until then had only possessed a fictitious registration. The evaluation was related to efficacy and safety within the indications claimed by the producers. Reviews and monographies had to be established for 445 basic compounds. One hundred positive and 30 negative monographies were published. "Negative" indicates that none of the claimed indications could be accepted by the committee. It is regrettable that the Federal Health Agency did not notice a considerable part of these negative evaluations until the present date. The process of the "Aufbereitung" was stopped abruptly by the 5th amendment of the German Drug Law in August 1994,--a very doubtful political decision with respect to drug safety in this country.

Central Nervous System Agents